BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Holistic medicine, Acetaminophen, rs3825942, SIRT1, glucose metabolic process, Liver)
Bookmark Forward

QuickView for METTL3;jsessionid=CCC6CC707DE4D4D530E7307B534F5B4C;jsessionid=D95CB6ECB629F73AE87DDCE58A045B75 (gene)


Body Atlas

Most Correlated Tissues

  1. Natural killer cell of peripheral blood
  2. T Lymphocyte (regulatory) of peripheral blood
  3. Hematopoietic stem cell of bone marrow
  4. Parotid gland
  5. Granulocyte-macrophage progenitor cell of bone marrow
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Bacterial sepsis of newborn
  2. Chronic fatigue syndrome
  3. Disease due to Arenavirus
  4. Rhinitis
  5. Finding related to pregnancy
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Atractyloside
  2. eburnamonine
  3. Probucol
  4. Cantharidin
  5. Piracetam
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. GIS2
  2. BAR1
  3. SET2
  4. METTL3
  5. METTL3
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. m6A methyltransferase METTL3 inhibits endometriosis by regulating alternative splicing of MIR17HG.
  2. Alternative splicing of METTL3 explains apparently METTL3-independent m6A modifications in mRNA.
  3. Mettl3-catalyzed m6A regulates histone modifier and modification expression in self-renewing somatic…
  4. Loss of Mettl3 enhances liver tumorigenesis by inducing hepatocyte dedifferentiation and hyperprolif…
  5. Kupffer cell pyroptosis mediated by METTL3 contributes to the progression of alcoholic steatohepatit…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for METTL3;jsessionid=CCC6CC707DE4D4D530E7307B534F5B4C;jsessionid=D95CB6ECB629F73AE87DDCE58A045B75
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.